forecast - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,828 +0.67%

DJIA 48,255 +0.72%

Nasdaq 25,055 +0.65%

DAX 23,889 -0.31%

Gold $4,196 +0.16%

Oil $97.95 +1.31%

BTC $71,982 +0.86%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,213 +0.19%

S&P 500 6,828 +0.67%

DJIA 48,255 +0.72%

Nasdaq 25,055 +0.65%

DAX 23,889 -0.31%

Gold $4,196 +0.16%

Oil $97.95 +1.31%

BTC $71,982 +0.86%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,213 +0.19%

forecast

Mavenclad packs under dramatic light symbolizing Merck KGaA Forecast pressure from 2026 patent expiry

Pharma & Healthcare·Stocks·USA

Merck KGaA Forecast Warning: 2026 Profit Hit Looms

By Maik Kemper • Mar 5, 2026

Mavenclad packs under dramatic light symbolizing Merck KGaA Forecast pressure from 2026 patent expiry

Pharma & Healthcare·Stocks·USA

Merck KGaA Forecast Warning: 2026 Profit Hit Looms

By Maik Kemper • Mar 5, 2026

Is the latest Merck KGaA Forecast a temporary setback before new growth, or the start of a longer earnings squeeze? Merck KGaA Forecast: What the…